Measures for batch issuance of biological products

On:
In: Approval, Medicine/medical devices, Regulation/Rule/Measure
The State Administration of market regulation promulgated the measures for the administration of batch issuance of biological products, which shall come into force on March 1, 2021. The national medical product administration-NMPA shall be responsible for the batch issuance of biological products nationwide and the on-site inspection. The national institutes for food and drug control-NIFDC organizes the formulation of technical requirements and assessment rules for batch issuance of biological products. The applicant shall establish a template for the summary of batch issuing production and inspection records of each variety. After the production and inspection of the product are completed, theRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. New Good Manufacture Practice for biological products
  2. New Measures for Road Motor Vehicle Enterprises and Products Access
  3. China issued the second batch of financial technology product
  4. Measures for the supervision of cosmetics production
  5. Measures for registration and filing of medical devices
  6. Certification Rules for commercial cryptography
  7. Measures for Registration of Infant Formula Milk Powder
  8. China implements certificate for edible agricultural products
  9. Measures of carbon emission trading
  10. Classification certification of green building materials (1st batch)